%0 Journal Article
%T Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer
%A Bhumsuk Keam
%A Dae Seog Heo
%A Dong-Wan Kim
%A Hoon-Gu Kim
%A Hwan Jung Yun
%A Jin-Soo Kim
%A Jong Seok Lee
%A Keon Uk Park
%A Min Kyoung Kim
%A Miso Kim
%A Seong Hoon Shin
%A Sung Sook Lee
%A Tae-Min Kim
%J Archive of "Cancer Research and Treatment : Official Journal of Korean Cancer Association".
%D 2017
%R 10.4143/crt.2016.121
%X The objective of this multicenter phase II study was to evaluate the efficacy and safety of irinotecan and cisplatin combination chemotherapy in metastatic, unresectable esophageal cancer
%K Esophageal neoplasms
%K Irinotecan
%K Cisplatin
%K Phase II clinical trial
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398400/